dupilumab - CAS 1190264-60-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C6512H10066N1730O2052S46
Molecular Weight:
146900
COA:
Inquire
Description:
Dupilumab is a monoclonal antibody used for the treatment of atopic diseases. In March 2017, its injection was approved by FDA for the treatment of moderate to severe atopic dermatitis when it is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
monoclonal antibody, atopic diseases
Synonyms:
Dupixent
MSDS:
Inquire
Application:
the treatment of atopic diseases
Current Developer:
Regeneron Pharmaceuticals; Sanofi Genzyme
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items